Health-care companies rose amid promising drug-development prospects.
Gilead Sciences rallied after one of the biotech company's drug candidates fared well in a breast-cancer trial.
Cardinal Health rose after activist investment firm Elliott Management reportedly purchased a significant stake in the medical-products distributor and will seek seats on the company's board.
The U.K. became the first country to approve Moderna's Omicron-targeting Covid-19 vaccine as a booster shot.
More than 2,000 mental-health workers for health-care provider Kaiser Permanente in Northern California went on strike as union negotiations stalled over wages and staffing levels.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
08-15-22 1702ET
